Fundraising Fox

Recode Ventures

Venture capital

San Francisco · 9 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

Recode Ventures believes that exponential technologies are transforming healthcare, and technology-native founders have an opportunity to apply rapid innovation to modernize an industry still relying on decades-old approaches. The firm's investment thesis is grounded in deep operational experience across the healthcare technology value chain, from early-stage ideation through regulatory approval, public markets, and strategic exits.

Source: firm website, verified Aug 6, 2026.

HQ
San Francisco, CA, US
Instruments
Equity
Tracked investments
11

Team · 9 people

from the firm's website & public directories

What they invest in

from 9 of 11 portfolio companies

AI & Machine Learning ×7Biotech ×6Healthtech ×5Deep Tech ×4Digital Health ×3Medical Devices ×3Advanced Manufacturing ×1Enterprise Software ×1

HQs:United States×3United Kingdom×1

Investments · 11 tracked

founders shown can be your intro path

By year:2023 · 12017 · 12 dated

Caption Carecaption-care.com

Caption Care delivers cardiac ultrasounds (echocardiograms) performed in clinics or patients' homes using AI-guided imaging and interpretation technology, enabling earlier detection of heart disease.

AI & Machine LearningDigital HealthMedical Devices

PartnerArmen A. Vidian· solo GP

Coincidence Labscoincidencelabs.comin

Coincidence Labs builds an AI orchestration layer that connects existing systems and digitizes paper records into a unified data layer, so AI agents can execute time-sensitive tasks like regulatory documentation with human review when needed.

Advanced ManufacturingAI & Machine LearningEnterprise Software

PartnerArmen A. Vidian· solo GP

LabGeniuslabgeni.usin𝕏Oct 2017

LabGenius develops EVA, an automated discovery engine for identifying and co-optimizing complex therapeutic antibodies such as multispecifics across multiple properties.

AI & Machine LearningBiotechDeep TechLondon

Harrison Rickerby(Executive Officer, Director)

BoardJames Field(Executive Officer, Director)

PartnerArmen A. Vidian· solo GP

Co-investorsAcequia Capital (AceCap)Air Street CapitalBackedBeast VenturesChampion Hill VenturesGigafund+9 more

Nanograbnanograb.comin𝕏

Nanograb develops gene therapy delivery systems using artificial intelligence to identify peptide-nanoparticle combinations that transport genetic medicines to targeted cells and tissues.

BiotechHealthtechSan Francisco, US

Debesh Mandal(Founder)inChristopher Lau(Founder)inShanil Panara(Founder)in

PartnerArmen A. Vidian· solo GP

Co-investorsSterling RoadY Combinator

PatientGeniepatientgenie.ai

PartnerArmen A. Vidian· solo GP

Persona-Dxpersona-dx.com

PartnerArmen A. Vidian· solo GP

Probably Geneticprobablygenetic.comin𝕏

Probably Genetic operates a platform for diagnosing genetic diseases, providing comprehensive genetic data and testing to patients and healthcare providers.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesSan Francisco, US

Lukas Lange(Founder)in

PartnerArmen A. Vidian· solo GP

Co-investorsAsymmetric Capital PartnersCalm/Storm VCManta Ray VenturesOxonian VenturesThreshold VenturesY Combinator+2 more

Propriopropriovision.comin𝕏

Proprio develops surgical technology using depth sensing and immersive image processing for the medical field.

AI & Machine LearningDeep TechHealthtechMedical DevicesSeattle, US

Gabriel Jones(Co-founder & CEO)Samuel Browd(Co-founder)Joshua Smith(Co-founder)James Youngquist(Co-founder)

PartnerArmen A. Vidian· solo GP

Co-investorsBold Capital PartnersCota CapitalDCVC (Data Collective)Bird B. AGHTCPresence Capital+4 more

Sensible Biotechnologiessensible.bioin𝕏Feb 2023

Sensible Biotechnologies develops a cell-based mRNA design and manufacturing platform that produces pure, low immunogenicity mRNA therapeutics for drug development.

AI & Machine LearningBiotechDeep TechHealthtechOxford, GB

Miroslav Gasparek(Founder)inMarian Kupculak(Founder)in

PartnerArmen A. Vidian· solo GP

Co-investorsCivilization Ventures Management, LlcKAYAY CombinatorZAKA VCBlueYard Capital

Verisianverisian.comin𝕏

Verisian builds software for clinical research and public health authorities to analyze and monitor clinical trial data in real-time, improving decision-making and trial safety.

BiotechDigital HealthHealthtechSaaS

BoardSunil Gupta(Strategic Advisor)

PartnerArmen A. Vidian· solo GP

Co-investorsCambridge Angels groupSuperSeed

Waypoint Biowaypointbio.comin𝕏

Waypoint Bio uses artificial intelligence, computer vision, and pooled screening to conduct deep phenotyping across thousands of cell therapy designs, enabling the discovery and optimization of superior cell therapy candidates for development.

AI & Machine LearningBiotechDeep Tech

Xinchen Wang, Ph.D.(Co-founder & CEO)David Phizicky, Ph.D.(Co-founder & CSO)Xinchen Wang(Founder)in

PartnerArmen A. Vidian· solo GP

Co-investorsAmplify PartnersFifty YearsHummingbird VenturesMBX CapitalMitsui Global InvestmentAmplify Partners CV+2 more

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Recode Ventures made?
Recode Ventures has 11 tracked investments.
What sectors does Recode Ventures focus on?
Recode Ventures focuses on Digital Health, Healthtech.
Where is Recode Ventures located?
Recode Ventures is headquartered in San Francisco, US.
Who does Recode Ventures co-invest with?
Recode Ventures most often shares deals with Y Combinator, DCVC (Data Collective), Hummingbird Ventures, among 35 tracked co-investors.

Media · Podcasts & interviews

featuring the team

Keynote: Peter Hebert, Lux Capital, and Armen Vidian, Recode Ventures | LSI USA '26

LSI - Life Science Intelligence™ · Armen Vidian

Images

Recode Ventures photo

Co-investors · 11

Lux Capital

Lux Capital is a venture capital firm that backs founders building transformative deep technologies, having been among the first investors in category-defining companies across AI, robotics, biotech, defense, and infrastructure.

$100K – $100M
DCVC (Data Collective)

DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.

Both backed · 1
$5M – $25M
Bold Capital Partners

Bold Capital Partners is a venture capital firm based in Los Angeles, California. Its portfolio includes companies such as Insilico Medicine, which applies artificial intelligence to biomarker development and drug discovery, reflecting a focus on frontier technologies in areas like AI-driven life sciences.

Both backed · 1
SuperSeed

SuperSeed is a seed-stage venture capital firm that invests in software startups, typically supporting companies through their initial growth phase toward £1m in revenue. The firm provides capital and operational guidance to early-stage founders.

Both backed · 1
$127K – $635K
Bling Capital

Bling Capital is a seed-stage venture firm that backs entrepreneurs seeking to find and scale product-market fit, supported by its Bling Product Council of over 100 product leaders.

$1M – $5M
UpHonest Capital

UpHonest Capital is a Silicon Valley-based investment firm founded in 2017 that supports cross-border entrepreneurship and investment between China and the United States, and runs media, scout, and incubation programs.

$50K – $1M
IA Ventures

IA Ventures is a venture capital firm that invests in early-stage software and frontier technology companies.

$1M – $3M
Passion Capital

Passion Capital is a UK-based early-stage venture firm founded in 2011 by Stefan Glaenzer, Eileen Burbidge, and Robert Dighero, focusing on digital media and technology investments. The founding partners bring combined experience from entrepreneurial and executive roles in technology companies.

Artis Ventures

Artis Ventures is a venture capital firm focused on supporting founders reimagining the systems that sustain life, spanning from cellular biology to broader societal impact.

$50K – $25M
Molten Ventures

Molten Ventures is a European venture capital firm that backs technology founders from Series A onward, providing capital along with operational expertise, networks, and partnership to help companies scale globally.

$2.5M – $63.5M
Foresite Capital

Foresite Capital is a multi-stage investment firm focused on healthcare and life sciences, backing companies across all stages of growth. It applies a data science-driven approach to invest in businesses leveraging biology and big data to transform healthcare.

Firms observed investing alongside Recode Ventures, from public investor directories. Shared companies are the overlap with Recode Ventures's recorded portfolio.

Similar investors

Featured in lists